Mycobacterial Implications in Crohn's and Chronic Inflammatory Diseases

Mycobacterial Implications in Crohn's and Chronic Inflammatory Diseases is organized by Human Paratuberculosis Foundation and will be held from Sep 21 - 22, 2018 at Lawrence Hall of Science, Berkeley, California, United States of America.

Course Description:
In September 2018, Human Paratuberculosis Foundation (HPF) and a group of dedicated researchers? will bring their experience and expertise to Berkeley, California for a two-day conference. Featuring presenters and experts from across the globe, this conference has been specifically designed to explore the role that mycobacteria, particularly Mycobacterium avium spp. paratuberculosis (MAP), may play in Crohn’s disease, Type 1 diabetes, multiple sclerosis and other chronic conditions.

Friday, September 21st will be open to the general public and health care professionals. Presentations from mycobacterial experts around world will discuss the latest developments in the field. Featured presenters include Prof. Thomas Borody (Australia), Dr. William Chamberlin (USA), John Aitken (New Zealand), Qu Biologics (Canada) and the Dr. Jeffrey Cox Lab (Berkeley, CA).

On Saturday, September 22nd, entry will be limited to doctors, researchers and health care professionals. An update on the Joint MAP Testing Study will begin the day, followed by panel discussions, and a think tank style working session.

Additional details will be posted as soon as they are available.